abstract |
FIELD: medicine.SUBSTANCE: invention refers to medicine, cardiology and gene therapy. Disclosed is an agent for treating atherosclerosis, which is a composition for inhibiting gene expression IL7R, IL7, TIGIT, CXCL8, F2RL1, EIF2AK3, TSPYL2, ANXA1, DUSP1 and IL15, closely related to accumulation of cholesterol by human macrophages. Composition consists of Curdlan nanoparticles acting as a carrier and siRNA specific to the above genes.EFFECT: invention provides creating a low-toxicity composition which suppresses gene expression IL7R, IL7, TIGIT, CXCL8, F2RL1, EIF2AK3, TSPYL2, ANXA1, DUSP1 and IL15.1 cl |